BERRUTI, ALFREDO
BERRUTI, ALFREDO
Dipartimento di Specialità Medico-Chirurgiche, Scienze Radiologiche e Sanità Pubblica
5th International ACC Symposium: Future and Current Therapeutic Trials in Adrenocortical Carcinoma
2016-01-01 Hoff, Ana O; Berruti, Alfredo
828PBONE METASTASES FROM RCC ARE NOT ALWAYS ASSOCIATED WITH A POOR PROGNOSIS
2014-01-01 Santini, D; Santoni, M; Conti, A; Procopio, G; Porta, C; Ibrahim, T; Barni, S; Fontana, A; Berruti, Alfredo; Vincenzi, B; Ortega, C; Carteni, G; Fedeli, S. L; Adamo, V; Maiello, E; Sabbatini, R; Felici, A; Tonini, G; Bracarda, S; Cascinu, S.
A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma
2022-01-01 Sigala, Sandra; Bothou, Christina; Penton, David; Abate, Andrea; Peitzsch, Mirko; Cosentini, Deborah; Tiberio, Guido A M; Bornstein, Stefan R; Berruti, Alfredo; Hantel, Constanze
A current perspective on treatment of adrenocortical carcinoma
2014-01-01 Terzolo, Massimo; De Francia, Silvia; Ardito, Arianna; Perotti, Paola; Ferrari, Laura; Berruti, Alfredo
A Database Tool Integrating Genomic and Pharmacologic Data from Adrenocortical Carcinoma (ACC) Cell Lines, PDX, and Patient Samples
2024-01-01 Arakawa, Yashuhiro; Elloumi, Fathi; Varma, Sudhir; Khandagale, Prashant; Jo, Ukhyun; Kumar, Suresh; Roper, Nitin; Reinhold, William C; Robey, Robert W; Takebe, Naoko; Gottesman, Michael M; Thomas, Craig J; Boeva, Valentina; Berruti, Alfredo; Abate, Andrea; Tamburello, Mariangela; Sigala, Sandra; Hantel, Constanze; Weigand, Isabel; Wierman, Margaret E; Kiseljak-Vassiliades, Katja; Del Rivero, Jaydira; Pommier, Yves
A new simple HPLC method for measuring mitotane and its two principal metabolites Tests in animals and mitotane-treated patients
2006-01-01 DE FRANCIA, S; Pirro, E; Zappia, F; DE MARTINO, F; Sprio, Ae; Daffara, F; Terzolo, M; Berruti, Alfredo; DI CARLO, F; Ghezzo, F.
A phase II trial of weekly paclitaxel and gemcitabine in non-small cell lung cancer patients previously treated with platinum and vinorelbine
2004-01-01 Dongiovanni, V; Addeo, A; Berruti, Alfredo; Buffoni, L; Dongiovanni, D; Polimeni, Ma; Fissore, C; Barone, C; Bertetto, O.
A pilot study evaluating serum pro-prostate-specific antigen in patients with rising PSA following radical prostatectomy. 2012 Apr 1;3(4):819-824. Epub 2012 Jan 16. PubMed Central PMCID: PMC3362404.
2012-01-01 Sottile, A; Ortega, C; Berruti, Alfredo; Mangioni, M; Saponaro, S; Polo, A; Prati, V; Muto, G; Aglietta, M; Montemurro, F.
A prospective study on adjuvant mitotane
2008-01-01 F., Daffara; B., Zaggia; A., Ardito; S., De Francia; G., Reimondo; M., Papotti; M., Volante; F., Di Carlo; A., Angeli; Berruti, Alfredo; M., Terzolo
A randomized comparison of high dose epirubicin versus high dose epirubicin plus lonidamine in advanced breast cancer patients. First results from a cooperative group study
1994-01-01 Dogliotti, L; Berruti, Alfredo; Buniva, T; Zola, P; Baù, Mg; Farris, A; Sarobba, Mg; Bottini, A; Alquati, P; Deltetto, F; Gosso, P; Monzeglio, C; Moro, G; Sussio, M; Perroni, D.
A Rare Complex BRAF Mutation Involving Codon V600 and K601 in Primary Cutaneous Melanoma: Case Report
2020-01-01 Consoli, F.; Barbieri, G.; Picciolini, M.; Medicina, D.; Bugatti, M.; Tovazzi, V.; Liserre, B.; Zambelli, C.; Zorzi, F.; Berruti, A.; Giurisato, E.; Vermi, W.
Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines
2019-01-01 Fragni, Martina; Galli, Diego; Nardini, Marco; Rossini, Elisa; Vezzoli, Sara; Zametta, Matteo; Longhena, Francesca; Bellucci, Arianna; Roca, Elisa; Memo, Maurizio; Berruti, Alfredo; Sigala, Sandra
Abiraterone and increased survival in metastatic prostate cancer
2011-01-01 Berruti, Alfredo; Pia, Anna; Terzolo, Massimo
Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents
2019-01-01 Tucci, M; Roca, E; Ferrari, L; Pia, L; Dalla Volta, A; Bedussi, F; Buttigliero, C; Vittorio Scagliotti, G; Sigala, S; Berruti, A
Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer
2017-01-01 Fizazi, Karim; Tran, Namphuong; Fein, Luis; Matsubara, Nobuaki; Rodriguez Antolin, Alfredo; Alekseev, Boris Y.; Ã zgã¼roglu, Mustafa; Ye, Dingwei; Feyerabend, Susan; Protheroe, Andrew; De Porre, Peter; Kheoh, Thian; Park, Youn C.; Todd, Mary B.; Chi, ; Kim N., Korbenfeld E; Metrebian, S; Kaen, L; Staneloni, E; Batagelj, E; Tan, H; Hovey, E; Woo, H; Frydenberg, M; Chua, W; D’Hondt, L; Evaraert, E; Verschaeve, V; Wynendaele, W; Schrijvers, D; Waltregny, D; Whenham, N; Demey, W; Franke, F; Panhoca, R; Damião, R; Zucca, L; Da Rosa, V; Reis, R; Scalabrini, A; Nahas, W; Girotto, G; Nogueira, A; Gomes, A; Coradazzi, A; Kurteva, G; Siemens, R; Gingerich, J; Fleshner, N; Fradet, Y; Morgan, S; North, S; Saad, F; Shayegan, B; Zalewski, P; Pinochet, R; Orellana, N; Ding, Q; Ye, Z; Xie, L; Du, C; Chen, Z; Huang, Y; Sun, Z; Li, H; Jin, J; Li, C; Wan, B; Tian, Y; Zhou, F; Xie, K; Yao, X; Qiu, M; Zou, Q; Na, Y; Sun, Y; Xue, B; Ma, L; Martinez, C; Salazar, M; Larios, C; Solano, S; Pavlik, I; Brodak, M; Hora, M; Büchler, T; Borre, M; Johansen, J; Mejlholm, I; Poulsen, M; Wittendorf, He; Tammela, T; Vaarala, M; Theodore, C; Staudacher, L; Villers, A; Laplaige, P; Suttman, H; Steuber, T; Natale, S; Jones, R; Tran, A; Mazhar, D; Mills, J; Nyirady, P; Salamon, C; Torzsok, F; Feher, J; Géczi, L; Lakatos, A; Keizman, D; Sella, A; Frank, S; Peer, A; Rosenbaum, E; Berger, R; Mermershtain, W; Carteni, G; Tonini, G; De Giorgi, U; Facchini, G; Berruti, Alfredo; Bracarda, S; Basso, U; Galli, L; Tortora, G; Alietta, M; Fukasawa, S; Suzuki, H; Hasumi, H; Tsuchiya, T; Uemura, H; Kanayama, H; Hashine, K; Sato, F; Matsumoto, H; Oya, M; Lee, Jl; Park, S; Keam, B; Yun, H; Kim, Y; Kang, B; Lee, K; Kim, C; Saad, M; Sundram, M; Calvo, D; Moreno, R; Rodriquez, J; Hernandez, C; van den Berg, H; De La Rosett, J; Van Moorse, R; Hunting, J; Hendriks, M; Kueppers, F; Gilling, P; Beaven, A; Holmes, M; Jassem, J; Oszukowska, E; Niezabitowski, J; Jaxa Larecka, D; Chwalinski, M; Swiniarski, P; Silva, C; Conceicãoa, P; Fraga, A; Mauricio, J; Rodrigues, T; Pinheiro, L; Lima, E; Palma Dos Reis, J; Volovat, C; Jinga, V; Harza, M; Alyasova, A; Budnik, N; Bychkov, Y; Izmaylov, A; Khvorosten, D; Matveev, V; Novsov, A; Vladimirov, V; Tevs, D; Sheveleva, L; Bulanov, A; Semenov, A; Fadeeva, N; Kulikov, E; Emelyanov, S; Karyakin, O; Shirinkin, V; Shkolnik, M; Lykov, A; Skopin, P; Kopyltsov, E; Mincik, I; Mir, O; Kliment, J; Mikurcik, E; Gajdos, M; Milichovsky, I; Malan, J; Bahlmann, J; Moshokoa, E; Madlala, T; Coetzee, L; Ribal, M; Miñana, B; Martinez Breijo, S; Carballido, J; Olmos, D; Requena, M; Morote, J; Damber, Je; Haggman, M; Nyman, C; Ljungberg, B; Bjartell, A; Ozen, H; Beduk, Y; Sozen, S; Cetinkaya, M; Ozyurt, M; Tansug, Z; Mungan, A; Tanidir, Y; Toktas, M; Hotko, E; Stus, V; Lyulko, O; Vinnyk, Y; Shparyk, Y; Sakalo, V; Bondarenko, I; Paramonov, V; Khareba, G; Hodos, V.
Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease
2001-01-01 Fiorentino, C.; Berruti, A.; Bottini, A.; Bodini, M.; Brizzi, M. P.; Brunelli, A.; Marini, U.; Allevi, G.; Aguggini, S.; Tira, A.; Alquati, P.; Olivetti, L.; Dogliotti, L.
Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease.
2001-01-01 Fiorentino, C; Berruti, Alfredo; Bottini, A; Bodini, M; Brizzi, Mp; Brunelli, A; Marini, U; Allevi, G; Aguggini, S; Tira, A; Alquati, P; Olivetti, L; Dogliotti, L.
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic
2021-01-01 Gurizzan, C.; Pedersini, R.; Fornaro, C.; Sardini, C.; Zamparini, M.; Monteverdi, S.; Tovazzi, V.; Cosentini, D.; Dalla Volta, A.; Baggi, A.; Turla, A.; Di Mauro, P.; Lorini, L.; Lagana, M.; Bianchi, S.; Grisanti, S.; Consoli, F.; Conti, E.; Bossi, P.; Berruti, A.
Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinoma
2009-01-01 Brizzi, Mp; Sculli, Cm; Ragni, F; Porpiglia, F; Tampellini, M; Gorzegno, G; Priola, Am; Dogliotti, L; Berruti, Alfredo
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients
2019-01-01 Cosentini, Deborah; Badalamenti, Giuseppe; Grisanti, Salvatore; Basile, Vittoria; Rapa, Ida; Cerri, Sara; Spallanzani, Andrea; Perotti, Paola; Musso, Emanuela; Laganà, Marta; Ferrari, Vittorio; Luppi, Gabriele; Dalla Volta, Alberto; Incorvaia, Lorena; Sigala, Sandra; Russo, Antonio; Volante, Marco; Terzolo, Massimo; Berruti, Alfredo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 5th International ACC Symposium: Future and Current Therapeutic Trials in Adrenocortical Carcinoma | 1-gen-2016 | Hoff, Ana O; Berruti, Alfredo | |
| 828PBONE METASTASES FROM RCC ARE NOT ALWAYS ASSOCIATED WITH A POOR PROGNOSIS | 1-gen-2014 | Santini, D; Santoni, M; Conti, A; Procopio, G; Porta, C; Ibrahim, T; Barni, S; Fontana, A; Berruti, Alfredo; Vincenzi, B; Ortega, C; Carteni, G; Fedeli, S. L; Adamo, V; Maiello, E; Sabbatini, R; Felici, A; Tonini, G; Bracarda, S; Cascinu, S. | |
| A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma | 1-gen-2022 | Sigala, Sandra; Bothou, Christina; Penton, David; Abate, Andrea; Peitzsch, Mirko; Cosentini, Deborah; Tiberio, Guido A M; Bornstein, Stefan R; Berruti, Alfredo; Hantel, Constanze | |
| A current perspective on treatment of adrenocortical carcinoma | 1-gen-2014 | Terzolo, Massimo; De Francia, Silvia; Ardito, Arianna; Perotti, Paola; Ferrari, Laura; Berruti, Alfredo | |
| A Database Tool Integrating Genomic and Pharmacologic Data from Adrenocortical Carcinoma (ACC) Cell Lines, PDX, and Patient Samples | 1-gen-2024 | Arakawa, Yashuhiro; Elloumi, Fathi; Varma, Sudhir; Khandagale, Prashant; Jo, Ukhyun; Kumar, Suresh; Roper, Nitin; Reinhold, William C; Robey, Robert W; Takebe, Naoko; Gottesman, Michael M; Thomas, Craig J; Boeva, Valentina; Berruti, Alfredo; Abate, Andrea; Tamburello, Mariangela; Sigala, Sandra; Hantel, Constanze; Weigand, Isabel; Wierman, Margaret E; Kiseljak-Vassiliades, Katja; Del Rivero, Jaydira; Pommier, Yves | |
| A new simple HPLC method for measuring mitotane and its two principal metabolites Tests in animals and mitotane-treated patients | 1-gen-2006 | DE FRANCIA, S; Pirro, E; Zappia, F; DE MARTINO, F; Sprio, Ae; Daffara, F; Terzolo, M; Berruti, Alfredo; DI CARLO, F; Ghezzo, F. | |
| A phase II trial of weekly paclitaxel and gemcitabine in non-small cell lung cancer patients previously treated with platinum and vinorelbine | 1-gen-2004 | Dongiovanni, V; Addeo, A; Berruti, Alfredo; Buffoni, L; Dongiovanni, D; Polimeni, Ma; Fissore, C; Barone, C; Bertetto, O. | |
| A pilot study evaluating serum pro-prostate-specific antigen in patients with rising PSA following radical prostatectomy. 2012 Apr 1;3(4):819-824. Epub 2012 Jan 16. PubMed Central PMCID: PMC3362404. | 1-gen-2012 | Sottile, A; Ortega, C; Berruti, Alfredo; Mangioni, M; Saponaro, S; Polo, A; Prati, V; Muto, G; Aglietta, M; Montemurro, F. | |
| A prospective study on adjuvant mitotane | 1-gen-2008 | F., Daffara; B., Zaggia; A., Ardito; S., De Francia; G., Reimondo; M., Papotti; M., Volante; F., Di Carlo; A., Angeli; Berruti, Alfredo; M., Terzolo | |
| A randomized comparison of high dose epirubicin versus high dose epirubicin plus lonidamine in advanced breast cancer patients. First results from a cooperative group study | 1-gen-1994 | Dogliotti, L; Berruti, Alfredo; Buniva, T; Zola, P; Baù, Mg; Farris, A; Sarobba, Mg; Bottini, A; Alquati, P; Deltetto, F; Gosso, P; Monzeglio, C; Moro, G; Sussio, M; Perroni, D. | |
| A Rare Complex BRAF Mutation Involving Codon V600 and K601 in Primary Cutaneous Melanoma: Case Report | 1-gen-2020 | Consoli, F.; Barbieri, G.; Picciolini, M.; Medicina, D.; Bugatti, M.; Tovazzi, V.; Liserre, B.; Zambelli, C.; Zorzi, F.; Berruti, A.; Giurisato, E.; Vermi, W. | |
| Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines | 1-gen-2019 | Fragni, Martina; Galli, Diego; Nardini, Marco; Rossini, Elisa; Vezzoli, Sara; Zametta, Matteo; Longhena, Francesca; Bellucci, Arianna; Roca, Elisa; Memo, Maurizio; Berruti, Alfredo; Sigala, Sandra | |
| Abiraterone and increased survival in metastatic prostate cancer | 1-gen-2011 | Berruti, Alfredo; Pia, Anna; Terzolo, Massimo | |
| Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents | 1-gen-2019 | Tucci, M; Roca, E; Ferrari, L; Pia, L; Dalla Volta, A; Bedussi, F; Buttigliero, C; Vittorio Scagliotti, G; Sigala, S; Berruti, A | |
| Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer | 1-gen-2017 | Fizazi, Karim; Tran, Namphuong; Fein, Luis; Matsubara, Nobuaki; Rodriguez Antolin, Alfredo; Alekseev, Boris Y.; Ã zgã¼roglu, Mustafa; Ye, Dingwei; Feyerabend, Susan; Protheroe, Andrew; De Porre, Peter; Kheoh, Thian; Park, Youn C.; Todd, Mary B.; Chi, ; Kim N., Korbenfeld E; Metrebian, S; Kaen, L; Staneloni, E; Batagelj, E; Tan, H; Hovey, E; Woo, H; Frydenberg, M; Chua, W; D’Hondt, L; Evaraert, E; Verschaeve, V; Wynendaele, W; Schrijvers, D; Waltregny, D; Whenham, N; Demey, W; Franke, F; Panhoca, R; Damião, R; Zucca, L; Da Rosa, V; Reis, R; Scalabrini, A; Nahas, W; Girotto, G; Nogueira, A; Gomes, A; Coradazzi, A; Kurteva, G; Siemens, R; Gingerich, J; Fleshner, N; Fradet, Y; Morgan, S; North, S; Saad, F; Shayegan, B; Zalewski, P; Pinochet, R; Orellana, N; Ding, Q; Ye, Z; Xie, L; Du, C; Chen, Z; Huang, Y; Sun, Z; Li, H; Jin, J; Li, C; Wan, B; Tian, Y; Zhou, F; Xie, K; Yao, X; Qiu, M; Zou, Q; Na, Y; Sun, Y; Xue, B; Ma, L; Martinez, C; Salazar, M; Larios, C; Solano, S; Pavlik, I; Brodak, M; Hora, M; Büchler, T; Borre, M; Johansen, J; Mejlholm, I; Poulsen, M; Wittendorf, He; Tammela, T; Vaarala, M; Theodore, C; Staudacher, L; Villers, A; Laplaige, P; Suttman, H; Steuber, T; Natale, S; Jones, R; Tran, A; Mazhar, D; Mills, J; Nyirady, P; Salamon, C; Torzsok, F; Feher, J; Géczi, L; Lakatos, A; Keizman, D; Sella, A; Frank, S; Peer, A; Rosenbaum, E; Berger, R; Mermershtain, W; Carteni, G; Tonini, G; De Giorgi, U; Facchini, G; Berruti, Alfredo; Bracarda, S; Basso, U; Galli, L; Tortora, G; Alietta, M; Fukasawa, S; Suzuki, H; Hasumi, H; Tsuchiya, T; Uemura, H; Kanayama, H; Hashine, K; Sato, F; Matsumoto, H; Oya, M; Lee, Jl; Park, S; Keam, B; Yun, H; Kim, Y; Kang, B; Lee, K; Kim, C; Saad, M; Sundram, M; Calvo, D; Moreno, R; Rodriquez, J; Hernandez, C; van den Berg, H; De La Rosett, J; Van Moorse, R; Hunting, J; Hendriks, M; Kueppers, F; Gilling, P; Beaven, A; Holmes, M; Jassem, J; Oszukowska, E; Niezabitowski, J; Jaxa Larecka, D; Chwalinski, M; Swiniarski, P; Silva, C; Conceicãoa, P; Fraga, A; Mauricio, J; Rodrigues, T; Pinheiro, L; Lima, E; Palma Dos Reis, J; Volovat, C; Jinga, V; Harza, M; Alyasova, A; Budnik, N; Bychkov, Y; Izmaylov, A; Khvorosten, D; Matveev, V; Novsov, A; Vladimirov, V; Tevs, D; Sheveleva, L; Bulanov, A; Semenov, A; Fadeeva, N; Kulikov, E; Emelyanov, S; Karyakin, O; Shirinkin, V; Shkolnik, M; Lykov, A; Skopin, P; Kopyltsov, E; Mincik, I; Mir, O; Kliment, J; Mikurcik, E; Gajdos, M; Milichovsky, I; Malan, J; Bahlmann, J; Moshokoa, E; Madlala, T; Coetzee, L; Ribal, M; Miñana, B; Martinez Breijo, S; Carballido, J; Olmos, D; Requena, M; Morote, J; Damber, Je; Haggman, M; Nyman, C; Ljungberg, B; Bjartell, A; Ozen, H; Beduk, Y; Sozen, S; Cetinkaya, M; Ozyurt, M; Tansug, Z; Mungan, A; Tanidir, Y; Toktas, M; Hotko, E; Stus, V; Lyulko, O; Vinnyk, Y; Shparyk, Y; Sakalo, V; Bondarenko, I; Paramonov, V; Khareba, G; Hodos, V. | |
| Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease | 1-gen-2001 | Fiorentino, C.; Berruti, A.; Bottini, A.; Bodini, M.; Brizzi, M. P.; Brunelli, A.; Marini, U.; Allevi, G.; Aguggini, S.; Tira, A.; Alquati, P.; Olivetti, L.; Dogliotti, L. | |
| Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease. | 1-gen-2001 | Fiorentino, C; Berruti, Alfredo; Bottini, A; Bodini, M; Brizzi, Mp; Brunelli, A; Marini, U; Allevi, G; Aguggini, S; Tira, A; Alquati, P; Olivetti, L; Dogliotti, L. | |
| Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic | 1-gen-2021 | Gurizzan, C.; Pedersini, R.; Fornaro, C.; Sardini, C.; Zamparini, M.; Monteverdi, S.; Tovazzi, V.; Cosentini, D.; Dalla Volta, A.; Baggi, A.; Turla, A.; Di Mauro, P.; Lorini, L.; Lagana, M.; Bianchi, S.; Grisanti, S.; Consoli, F.; Conti, E.; Bossi, P.; Berruti, A. | |
| Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinoma | 1-gen-2009 | Brizzi, Mp; Sculli, Cm; Ragni, F; Porpiglia, F; Tampellini, M; Gorzegno, G; Priola, Am; Dogliotti, L; Berruti, Alfredo | |
| Activity and safety of temozolomide in advanced adrenocortical carcinoma patients | 1-gen-2019 | Cosentini, Deborah; Badalamenti, Giuseppe; Grisanti, Salvatore; Basile, Vittoria; Rapa, Ida; Cerri, Sara; Spallanzani, Andrea; Perotti, Paola; Musso, Emanuela; Laganà, Marta; Ferrari, Vittorio; Luppi, Gabriele; Dalla Volta, Alberto; Incorvaia, Lorena; Sigala, Sandra; Russo, Antonio; Volante, Marco; Terzolo, Massimo; Berruti, Alfredo |